architissue – 3d architecture of biohybrid heart valves

1
74 Subject to alterations in specifications and other technical information. 07/2021. 1 Removal of a 3D scaffold green body from the SLA system. 2 Light microscopic image of a 3D scaffold structure. Task As life expectancy rises, society in general ages and diseases typical of old age increase. One of the most common of these diseases is heart failure, the cause of which includes diseases or malfunctions of the heart valve. Today’s heart valve replacements, whether of biological or technical origin, have several disadvantages. Biohybrid soft tissue implants represent a promising alternative in this respect. By using a durable, reinforcing scaffold as technical component surrounded by the patient’s own cells as a biological component, research can exploit the innovative potential of heart valve replacements specifically adapted and highly compatible to the patient. The production of the required 3D scaffold structures is being examined using laser-based stereolithography. Method To fabricate 3D scaffold structures, the Chair for Laser Tech- nology LLT and Fraunhofer ILT are using current insights into photoinitiator-free photochemical polymerization to combine it with innovative stereolithography for processing hot-melt photopolymers. The biofabrication group is developing high viscosity thiol-ene photopolymers to improve their mechanical stability and elasticity as well as their biocompatibility, and processing them with high resolution stereolithography. To tailor the mechanical properties of the 3D scaffolds, the group is also systematically exploring different unit cell designs as well as their spatial arrangement. Results Laser stereolithography was used to manufacture 3D scaffold structures and to adapt their mechanical properties by both dimensioning the scaffold architecture and adjusting the photopolymer composition. The unit cells used range in size from a few micrometers to a few millimeters in edge length. Proliferation and cytotoxicity tests were used to demonstrate that the polymers are biocompatible. Applications Biocompatible scaffolds are mainly produced for novel implants in regenerative medicine and for organoid test systems in the pharmaceutical industry. Furthermore, 3D microstructured polymeric materials can be used to open up new possibilities for producing adaptive components in the plastics industry. The ArchiTissue project is funded by the German Research Foundation (DFG) under the reference number 403170227. Contact Klaus Kreuels M. Sc., Ext.: -8183 [email protected] Dr. Arnold Gillner, Ext.: -148 [email protected] ARCHITISSUE – 3D ARCHI- TECTURE OF BIOHYBRID HEART VALVES MADE WITH ADDITIVE MANUFACTURING 1 2

Upload: others

Post on 24-Feb-2022

1 views

Category:

Documents


0 download

TRANSCRIPT

74

MF Annual Report 2019 Annual Report 2020 MF

Sub

ject

to

alt

erat

ion

s in

sp

ecifi

cati

on

s an

d o

ther

tec

hn

ical

info

rmat

ion

. 07/

2021

.

Fraunhofer Institute for Laser Technology ILT, www.ilt.fraunhofer.de

DQS certified by DIN EN ISO 9001, Reg.-No.: DE-69572-01

Fraunhofer Institute for Laser Technology ILT, www.ilt.fraunhofer.de

DQS certified by DIN EN ISO 9001, Reg.-No.: DE-69572-01

Sub

ject

to

alt

erat

ion

s in

sp

ecifi

cati

on

s an

d o

ther

tec

hn

ical

info

rmat

ion

. 07/

2021

.

1 Removal of a 3D scaffold green body

from the SLA system.

2 Light microscopic image of a 3D scaffold structure.

Task

As life expectancy rises, society in general ages and diseases

typical of old age increase. One of the most common of

these diseases is heart failure, the cause of which includes

diseases or malfunctions of the heart valve. Today’s heart valve

replacements, whether of biological or technical origin, have

several disadvantages. Biohybrid soft tissue implants represent

a promising alternative in this respect. By using a durable,

reinforcing scaffold as technical component surrounded by

the patient’s own cells as a biological component, research can

exploit the innovative potential of heart valve replacements

specifically adapted and highly compatible to the patient.

The production of the required 3D scaffold structures is being

examined using laser-based stereolithography.

Method

To fabricate 3D scaffold structures, the Chair for Laser Tech-

nology LLT and Fraunhofer ILT are using current insights into

photoinitiator-free photochemical polymerization to combine

it with innovative stereolithography for processing hot-melt

photopolymers. The biofabrication group is developing high

viscosity thiol-ene photopolymers to improve their mechanical

stability and elasticity as well as their biocompatibility, and

processing them with high resolution stereolithography. To

tailor the mechanical properties of the 3D scaffolds, the group

is also systematically exploring different unit cell designs as

well as their spatial arrangement.

Results

Laser stereolithography was used to manufacture 3D scaffold

structures and to adapt their mechanical properties by both

dimensioning the scaffold architecture and adjusting the

photopolymer composition. The unit cells used range in size

from a few micrometers to a few millimeters in edge length.

Proliferation and cytotoxicity tests were used to demonstrate

that the polymers are biocompatible.

Applications

Biocompatible scaffolds are mainly produced for novel

implants in regenerative medicine and for organoid test

systems in the pharmaceutical industry. Furthermore, 3D

microstructured polymeric materials can be used to open up

new possibilities for producing adaptive components in the

plastics industry.

The ArchiTissue project is funded by the German Research

Foundation (DFG) under the reference number 403170227.

Contact

Klaus Kreuels M. Sc., Ext.: -8183

[email protected]

Dr. Arnold Gillner, Ext.: -148

[email protected]

ARCHITISSUE – 3D ARCHI-TECTURE OF BIOHYBRID HEART VALVES MADE WITH ADDITIVE MANUFACTURING

1 2